BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36707720)

  • 21. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.
    Schultz AP; Kloet RW; Sohrabi HR; van der Weerd L; van Rooden S; Wermer MJH; Moursel LG; Yaqub M; van Berckel BNM; Chatterjee P; Gardener SL; Taddei K; Fagan AM; Benzinger TL; Morris JC; Sperling R; Johnson K; Bateman RJ; ; Gurol ME; van Buchem MA; Martins R; Chhatwal JP; Greenberg SM
    Ann Neurol; 2019 Oct; 86(4):616-625. PubMed ID: 31361916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
    Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis.
    Margraf NG; Jensen-Kondering U; Weiler C; Leypoldt F; Maetzler W; Philippen S; Bartsch T; Flüh C; Röcken C; Möller B; Royl G; Neumann A; Brüggemann N; Roeben B; Schulte C; Bender B; Berg D; Kuhlenbäumer G
    Front Aging Neurosci; 2022; 14():783996. PubMed ID: 35237145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy.
    Koemans EA; Castello JP; Rasing I; Abramson JR; Voigt S; Perosa V; van Harten TW; van Zwet EW; Terwindt GM; Gurol ME; Rosand J; Greenberg SM; van Walderveen MAA; Biffi A; Viswanathan A; Wermer MJH
    Stroke; 2023 Feb; 54(2):306-314. PubMed ID: 36689586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy.
    Vervuurt M; Kuiperij HB; de Kort AM; Kersten I; Klijn CJM; Schreuder FHBM; Verbeek MM
    Alzheimers Res Ther; 2024 May; 16(1):108. PubMed ID: 38745197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
    Jäkel L; Boche D; Nicoll JAR; Verbeek MM
    Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
    J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
    Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients.
    Vervuurt M; Schrader JM; de Kort AM; Kersten I; Wessels HJCT; Klijn CJM; Schreuder FHBM; Kuiperij HB; Gloerich J; Van Nostrand WE; Verbeek MM
    Acta Neuropathol Commun; 2024 Jan; 12(1):6. PubMed ID: 38191511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
    Mulugeta E; Londos E; Ballard C; Alves G; Zetterberg H; Blennow K; Skogseth R; Minthon L; Aarsland D
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):160-4. PubMed ID: 21047883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration.
    Ortner M; Goldhardt O; Diehl-Schmid J; Yakushev I; Lanz K; Hedderich DM; Manuilova E; Simon M; Weinberger JP; Grimmer T
    J Prev Alzheimers Dis; 2022; 9(3):491-498. PubMed ID: 35841250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.
    Piazza F; Greenberg SM; Savoiardo M; Gardinetti M; Chiapparini L; Raicher I; Nitrini R; Sakaguchi H; Brioschi M; Billo G; Colombo A; Lanzani F; Piscosquito G; Carriero MR; Giaccone G; Tagliavini F; Ferrarese C; DiFrancesco JC
    Ann Neurol; 2013 Apr; 73(4):449-58. PubMed ID: 23625526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal Fluid Biomarkers in Dementia Patients with Cerebral Amyloid Angiopathy.
    Li YF; Ge FF; Zhang Y; You H; Zhang ZX
    Chin Med Sci J; 2015 Sep; 30(3):170-3. PubMed ID: 26564416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    van den Berg E; Nilsson J; Kersten I; Brinkmalm G; de Kort AM; Klijn CJM; Schreuder FHBM; Jäkel L; Gobom J; Portelius E; Zetterberg H; Brinkmalm A; Blennow K; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2023; 92(2):467-475. PubMed ID: 36776062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
    Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
    Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subarachnoid CSF hyperintensities at 7 tesla FLAIR MRI: A novel marker in cerebral amyloid angiopathy.
    Koemans EA; van Walderveen MAA; Voigt S; Rasing I; van Harten TW; J A van Os H; van der Weerd N; Terwindt GM; van Osch MJP; van Veluw SJ; Freeze WM; Wermer MJH
    Neuroimage Clin; 2023; 38():103386. PubMed ID: 36989852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.
    Renard D; Gabelle A; Hirtz C; Demattei C; Thouvenot E; Lehmann S
    J Alzheimers Dis; 2016 Oct; 54(4):1291-1295. PubMed ID: 27567848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy.
    Verbeek MM; Kremer BP; Rikkert MO; Van Domburg PH; Skehan ME; Greenberg SM
    Ann Neurol; 2009 Aug; 66(2):245-9. PubMed ID: 19743453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial.
    Voigt S; Koemans EA; Rasing I; van Etten ES; Terwindt GM; Baas F; Kaushik K; van Es ACGM; van Buchem MA; van Osch MJP; van Walderveen MAA; Klijn CJM; Verbeek MM; van der Weerd L; Wermer MJH
    Trials; 2023 Jun; 24(1):378. PubMed ID: 37277877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.